Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence

  • Gabriella Ferrandina, Floriana Mascilini, Giulia Amadio, Maria Grazia Di Stefano, Alessia Di Legge, Rosa De Vincenzo, Valeria Masciullo, Vanda Salutari, Giovanni Scambia, Conte, Manuela Ludovisi, Ricci
  • OncoTargets and Therapy, July 2014, Taylor & Francis
  • DOI: 10.2147/ott.s51550

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Mariagrazia Distefano